Frontiers in Endocrinology · 2023 · 39 citations · 49 references
The study revealed that an adequate VD level may act as a protective factor in NAFLD and that VD may alleviate hepatic steatosis <i>via</i> the PPARα signaling pathway.
49
Inhibition of peroxisome-proliferator-activated receptor (PPAR)α by MK886
James P. Kehrer, Shyam Biswal, Eunhye La et al. · Biochemical Journal · 2001 · 150 citations · Full text
Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity
Yan Fang, Qi Wang, Ming Lu et al. · Journal of Hepatology · 2014 · 142 citations